Medexus Pharmaceuticals Inc. (TSX:MDP)

Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 10, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	92	78	39	32	63	151
Market Cap Growth	44.54%	98.25%	21.95%	-48.46%	-58.62%	335.06%
Enterprise Value	109	123	98	109	118	204
Last Close Price	2.85	2.42	1.61	1.60	3.14	7.90
PE Ratio	73.49	24.17	-	19.55	-	-
Forward PE	41.91	-	-	-	-	-
PS Ratio	0.64	0.50	0.26	0.22	0.65	1.51
PB Ratio	1.27	1.04	0.96	1.06	2.82	6.68
P/FCF Ratio	3.47	2.28	1.56	-	-	24.45
P/OCF Ratio	3.42	2.26	1.55	-	-	23.88
EV/Sales Ratio	0.76	0.79	0.64	0.74	1.23	2.04
EV/EBITDA Ratio	4.81	4.53	3.91	5.59	-	25.52
EV/EBIT Ratio	9.49	7.20	5.64	9.46	-	221.81
EV/FCF Ratio	4.11	3.60	3.86	-	-	32.94
Debt / Equity Ratio	0.41	0.71	1.65	3.12	3.08	2.49
Debt / EBITDA Ratio	1.32	1.95	2.68	4.81	-	6.69
Debt / FCF Ratio	1.12	1.56	2.67	-	-	9.12
Asset Turnover	0.70	0.66	0.71	0.72	0.53	0.59
Inventory Turnover	1.18	1.17	1.61	1.92	1.83	2.24
Quick Ratio	0.28	0.38	0.44	0.43	0.51	0.94
Current Ratio	0.81	0.83	1.10	0.87	1.02	1.47
Return on Equity (ROE)	1.88%	5.45%	-0.81%	6.07%	-16.08%	-133.66%
Return on Assets (ROA)	3.50%	4.55%	5.04%	3.53%	-5.38%	0.34%
Return on Capital (ROIC)	6.84%	8.79%	9.25%	6.42%	-11.41%	0.73%
Return on Capital Employed (ROCE)	11.30%	16.00%	14.30%	10.90%	-	0.70%
Earnings Yield	1.19%	4.14%	-0.74%	5.12%	-5.74%	-23.48%
FCF Yield	28.86%	43.91%	64.18%	-6.31%	-2.54%	4.09%
Buyback Yield / Dilution	-21.73%	-18.76%	-8.76%	-3.36%	-30.65%	-5.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.